By Jonathan Stempel NEW YORK, Dec 2 (Reuters) - CVS Health will pay $37.76 million to settle allegations it dispensed too ...

The "U.S. Insulin Pen Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been ...

Rising Diabetes Rates and Digital InnovatioFuel European Insulin Pen Market Growth European Insulin Pen Market European ...

Adults with type 1 diabetes using a continuous glucose monitoring system with a smart insulin pen attained a higher time in range if they responded more frequently to alerts for missed doses or high ...

Switzerland: Adults with type 1 diabetes using CGM and a smart insulin pen achieved higher time in range when they ...

Getting to grips with rising diabetes rates is arguably one of the most urgent tasks for South Africa's public healthcare system, but the setbacks keep coming. While some communities are facing ...

Ozempic, the globally sought-after semaglutide injection that has dominated conversations around diabetes care and weight loss, has finally entered the Indian market. With it, an immediate surge of ...

For almost two-thirds of his life, Nick Jonas has lived with a chronic condition — type 1 diabetes. The Jonas Brothers-famed ...

As per SNS Insider Research, North America Leads the Market with 42% Market Share, While Asia Pacific Emerges as the Fastest Growing Region with Strong Adoption of Connected Diabetes ...

CVS will pay for dispensing and billing health care plans including Tricare for more insulin than was prescribed, according to a lawsuit settlement.

Introducing Ozempic, a groundbreaking GLP-1 agonist now making waves in India! This innovative treatment emulates a natural ...